drugset / Trial / NCT00357123

Effect of Rosuvastatin in Abdominal Sepsis

NCT00357123

Phase 2 Unknown 60 enrolled Autonomous University of San Luis Potosí
RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether rosuvastatin is effective as a coadjuvant drug in the integral management of abdominal sepsis acknowledged by surgery.

Timeline

Start
2006-08
Primary completion
2011-07
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg